Recent Company News

• 04:02 AM ET Jan 15, 2025
  

  StreetAccount Summary - Trading higher/lower: EU mid-morning

• 02:22 AM ET Apr 30, 2025
  

  FDA approves Genus's PRRS Resistant Pig gene edit for use in US food supply chain (1586.0000p, 0)

• 03:06 AM ET Mar 13, 2025
  

  Genus appoints Andy Russell as CFO, effective 1-Aug (1914.0000p, 0)

• 02:18 AM ET Feb 27, 2025
  

  Genus reports H1 adjusted PBT £35.4M vs FactSet £35.2M and guidance of at least £35M (1830.0000p, 0)

• 03:22 AM ET Feb 17, 2025
  

  Genus initiated buy at Singer Capital Markets (pre-open) (1856.0000p, -12)

• 02:30 AM ET Jan 29, 2025
  

  Genus initiated buy at BofA (1774.0000p, 0)

• 02:11 AM ET Jan 15, 2025
  

  Genus H1 trading update: expects to report Group adjusted PBT of at least £35M in actual currency, which is ahead of expectations (1424.0000p, 0)